Human Medications, Human Drugs, Animal Medications, Animal Drugs, Pharmacy law, Pharmaceutical law, Compounding law, Sterile and Non Sterile Compounding 797 Compliance, Veterinary law, Veterinary
Compounding Law; Health Care; Awareness of all Types of Compounding Issues;
Pharmacy Benefit Managers (PBMs), Outsourcing Facilities
Food and Drug Administration and Compliance Issues
Pages
▼
Tuesday, April 2, 2013
Compounder’s Recall Reignites Congressional Criticism of FDA
Drug GMP Report
April 2013
A recent recall by a New Jersey-based specialty pharmacy has reignited congressional criticism that the FDA is not doing enough to protect the public from contaminated compounded drugs.
This article is viewable by subscribers only. To view this article, please select an option below. click here
No comments:
Post a Comment